Shares of Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF – Get Free Report) hit a new 52-week low during trading on Friday . The company traded as low as $52.25 and last traded at $52.25, with a volume of 0 shares traded. The stock had previously closed at $52.25.
Recordati Industria Chimica e Farmaceutica Price Performance
The firm’s fifty day simple moving average is $52.12 and its two-hundred day simple moving average is $51.78. The company has a current ratio of 1.36, a quick ratio of 0.95 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $10.78 billion, a price-to-earnings ratio of 18.80 and a beta of 0.33.
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last released its quarterly earnings data on Tuesday, July 30th. The company reported $0.70 EPS for the quarter. The firm had revenue of $622.00 million for the quarter. Recordati Industria Chimica e Farmaceutica had a return on equity of 30.78% and a net margin of 17.41%.
Recordati Industria Chimica e Farmaceutica Company Profile
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Featured Articles
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- How to Invest in Biotech Stocks
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- Consumer Discretionary Stocks Explained
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.